Physician profile
Jeffrey L Chen
NPI 1811183700
$59,031.48
in general payments reported to CMS, 2019-2025
25 companies · $4,227 in 2025
The $4,227 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,077 · 2020: $4,643 · 2021: $6,189 · 2022: $9,043 · 2023: $5,033 · 2024: $26K · 2025: $4,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $8,762 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,700 · Travel and Lodging: $1,624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,993.75 |
| Food and Beverage | $8,761.70 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,700.00 |
| Travel and Lodging | $1,624.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15,376.32 | 2023-2025 | None, Stimrouter Implantable Kit, Stimrouter Implantable Kit |
| Vertos Medical, INC. | $9,918.75 | 2020-2024 | Mild Device Kit |
| Boston Scientific Corporation | $7,019.16 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Abbott Laboratories | $6,672.94 | 2019-2025 | Proclaim, Eterna, Octrode |
| Stryker Corporation | $5,617.51 | 2019-2024 | Mild Device Kit |
| Merz Pharmaceuticals, LLC | $2,899.67 | 2024-2025 | Xeomin |
| Spinal Simplicity, LLC | $2,063.31 | 2021 | |
| Vertiflex, INC. | $1,791.60 | 2019 | |
| Relievant Medsystems, INC. | $1,553.19 | 2020-2023 | Intracept |
| Medtronic, INC. | $1,118.22 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Nevro Corp. | $1,064.29 | 2019-2023 | Senza |
| Nalu Medical, INC. | $1,010.21 | 2020-2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $771.54 | 2019-2020 | |
| Spr Therapeutics, INC | $566.86 | 2019-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $414.67 | 2023-2025 | Evoke Scs, Evoke |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $353.45 | 2023-2024 | Painteq |
| Globus Medical, INC. | $162.81 | 2025 | Vyrsa V1 |
| Si-Bone, INC. | $151.43 | 2024 | |
| Tenex Health INC. | $123.47 | 2019-2021 | |
| Trice Medical, INC. | $113.58 | 2022-2025 | |
| Cognoa, INC. | $95.30 | 2023 | Canvas Dx |
| Biogen, INC. | $64.77 | 2020-2021 | |
| Grt US Holding, INC. | $54.47 | 2022 | |
| Merz North America, INC. | $34.73 | 2020 | |
| Abbvie INC. | $19.23 | 2023 | Botox |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.